Literature DB >> 22687188

The aggregate nature of human mesenchymal stromal cells in native bone marrow.

Naser Ahmadbeigi1, Masoud Soleimani, Farshad Babaeijandaghi, Yousef Mortazavi, Yousof Gheisari, Mohammad Vasei, Kayhan Azadmanesh, Shahrbano Rostami, Abbas Shafiee, Nance Beyer Nardi.   

Abstract

BACKGROUND AIMS: The clinical application of mesenchymal stromal cells (MSC) faces several obstacles, such as the lack of a standard method for direct isolation as well as a low frequency and concern about the safety of their in vitro expansion. Although the density-gradient separation technique is used as the first step in most methods of MSC isolation to enrich mononuclear cells, the efficiency of this method has not so far been examined. This study was designed to address this issue.
METHODS: Human bone marrow (BM) samples were laid over Ficoll-Paque, and after centrifugation the upper and lower fractions were cultured separately. Surface markers, differentiation potential and the number of emerged cells were determined.
RESULTS: The isolated cells from both the upper and lower fractions were characteristic of MSC. Although it is commonly believed that MSC are single suspending mononuclear cells and so are enriched in the upper fraction of Ficoll-Paque after density-gradient separation, our data showed that considerable numbers of these cells were accumulated in the lower fraction. Further data indicated that MSC were actually present as cell aggregates in BM and they could be enriched effectively by a simple filtration method.
CONCLUSIONS: The aggregate nature of MSC in BM is in agreement with the concept that they are one of the main elements of the hematopoietic stem cell niche. In addition, the simple filtration method proposed here to isolate cell aggregates may provide opportunities for instant stem cell therapy without the need for extensive in vitro expansion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22687188     DOI: 10.3109/14653249.2012.689426

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  9 in total

1.  Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration.

Authors:  Elena Veronesi; Alba Murgia; Anna Caselli; Giulia Grisendi; Maria Serena Piccinno; Valeria Rasini; Rosaria Giordano; Tiziana Montemurro; Philippe Bourin; Luc Sensebé; Markus T Rojewski; Hubert Schrezenmeier; Pierre Layrolle; Maria Pau Ginebra; Carmen Bunu Panaitescu; Enrique Gómez-Barrena; Fabio Catani; Paolo Paolucci; Jorge S Burns; Massimo Dominici
Journal:  Tissue Eng Part C Methods       Date:  2013-08-20       Impact factor: 3.056

2.  Effective Label-Free Sorting of Multipotent Mesenchymal Stem Cells from Clinical Bone Marrow Samples.

Authors:  Silvia Zia; Carola Cavallo; Ilaria Vigliotta; Valentina Parisi; Brunella Grigolo; Roberto Buda; Pasquale Marrazzo; Francesco Alviano; Laura Bonsi; Andrea Zattoni; Pierluigi Reschiglian; Barbara Roda
Journal:  Bioengineering (Basel)       Date:  2022-01-22

3.  Isolation, characterization, and transplantation of bone marrow-derived cell components with hematopoietic stem cell niche properties.

Authors:  Naser Ahmadbeigi; Masoud Soleimani; Mohammad Vasei; Yousof Gheisari; Yousef Mortazavi; Kayhan Azadmanesh; Azadeh Omidkhoda; Ehsan Janzamin; Nance Beyer Nardi
Journal:  Stem Cells Dev       Date:  2013-09-14       Impact factor: 3.272

4.  Density gradient centrifugation compromises bone marrow mononuclear cell yield.

Authors:  Claudia Pösel; Karoline Möller; Wenke Fröhlich; Isabell Schulz; Johannes Boltze; Daniel-Christoph Wagner
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

Review 5.  Benchtop technologies for circulating tumor cells separation based on biophysical properties.

Authors:  Wan Shi Low; Wan Abu Bakar Wan Abas
Journal:  Biomed Res Int       Date:  2015-04-21       Impact factor: 3.411

6.  Different Methylation Patterns of RUNX2, OSX, DLX5 and BSP in Osteoblastic Differentiation of Mesenchymal Stem Cells.

Authors:  Majid Farshdousti Hagh; Mehrdad Noruzinia; Yousef Mortazavi; Masood Soleimani; Saeed Kaviani; Saeed Abroun; Ali Dehghani Fard; Maryam Mahmoodinia
Journal:  Cell J       Date:  2015-04-08       Impact factor: 2.479

7.  Combined Analysis of Endothelial, Hematopoietic, and Mesenchymal Stem Cell Compartments Shows Simultaneous but Independent Effects of Age and Heart Disease.

Authors:  Carine Ghem; Lucinara Dadda Dias; Roberto Tofani Sant'Anna; Renato A K Kalil; Melissa Markoski; Nance Beyer Nardi
Journal:  Stem Cells Int       Date:  2017-07-27       Impact factor: 5.443

8.  Isolation of clinically relevant concentrations of bone marrow mesenchymal stem cells without centrifugation.

Authors:  Michael Scarpone; Daniel Kuebler; Andrew Chambers; Carlo Maria De Filippo; Mariangela Amatuzio; Thomas E Ichim; Amit N Patel; Eugenio Caradonna
Journal:  J Transl Med       Date:  2019-01-05       Impact factor: 5.531

9.  Bone regeneration in rat calvarial defects using dissociated or spheroid mesenchymal stromal cells in scaffold-hydrogel constructs.

Authors:  Siddharth Shanbhag; Salwa Suliman; Samih Mohamed-Ahmed; Carina Kampleitner; Mohamed Nageeb Hassan; Patrick Heimel; Toni Dobsak; Stefan Tangl; Anne Isine Bolstad; Kamal Mustafa
Journal:  Stem Cell Res Ther       Date:  2021-11-14       Impact factor: 6.832

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.